Laser and photodynamic therapy for esophageal cancer.
Esophageal cancer has a poor prognosis. The diagnosis in clinical practise is often made in advanced stages when curative treatment is impossible. Overall five year survival is reached only in 10% of patients and a palliative treatment is indicated in 60% of patients. From these patients one year survival could be observed in 55% and five year survival only in about 20% of patients. Progressive dysphagia is responsible for the poor quality of life. (Ref. 4.).
Mlkvy
P
P
St. Elizabeth Oncology Hospital, Bratislava, Slovakia. bll@fmed.uniba.sk
Makovnik
P
P
Majek
J
J
Slezak
P
P
Kollar
T
T
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004938:Esophageal Neoplasms / Q000628:therapy*; D006801:Humans; D053685:Laser Therapy; D008875:Middle Aged; D010166:Palliative Care; D010778:Photochemotherapy